AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] ModivCare Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

ModivCare Inc. disclosed it commenced voluntary Chapter 11 bankruptcy proceedings on August 20, 2025 and received Nasdaq notices that it is no longer suitable for listing and is delinquent in regulatory filings. Nasdaq determined to commence delisting proceedings and informed the company the common stock would be suspended at the opening of business on August 28, 2025. The company does not intend to appeal and expects Nasdaq to file to remove the listing, after which the stock may quote on the OTC Pink market, though that is not assured.

ModivCare Inc. ha comunicato di aver avviato volontariamente il procedimento di fallimento ai sensi del Capitolo 11 il 20 agosto 2025 e di aver ricevuto avvisi dalla Nasdaq che non è più idonea alla quotazione e che è in ritardo nelle comunicazioni regolamentari. Nasdaq ha deciso di avviare la procedura di esclusione dalla quotazione e ha informato la società che le azioni ordinarie saranno sospese all'apertura delle contrattazioni il 28 agosto 2025. La società non intende presentare ricorso e prevede che Nasdaq chiederà la rimozione dalla quotazione; successivamente le azioni potrebbero essere negoziate sul mercato OTC Pink, sebbene ciò non sia garantito.

ModivCare Inc. informó que inició voluntariamente procedimientos de bancarrota bajo el Capítulo 11 el 20 de agosto de 2025 y recibió avisos de Nasdaq de que ya no es apta para cotizar y que tiene retrasos en las presentaciones regulatorias. Nasdaq decidió iniciar el proceso de exclusión y notificó a la compañía que las acciones ordinarias se suspenderán a la apertura del mercado el 28 de agosto de 2025. La compañía no piensa apelar y espera que Nasdaq solicite la remoción de la cotización; tras ello las acciones podrían cotizar en el mercado OTC Pink, aunque no es seguro.

ModivCare Inc.ëŠ� 2025ë…� 8ì›� 20ì� ìžë°œì ìœ¼ë¡� 챕터 11 파산 절차ë¥� 개시했으ë©�, 나스닥으로부í„� ë� ì´ìƒ ìƒìž¥ ì ê²©ì„±ì´ 없고 규제 서류 제출ì� ì—°ì²´ë˜ì—ˆë‹¤ëŠ” 통지ë¥� 받았다고 공개했습니다. ë‚˜ìŠ¤ë‹¥ì€ ìƒìž¥íì§€ 절차ë¥� 개시하기ë¡� 결정하고 2025ë…� 8ì›� 28ì� 개장 ì‹� 보통주가 거래정지ë� 것ì´ë¼ê³  회사ì—� 통보했습니다. 회사ëŠ� 항소í•� ì˜ì‚¬ê°€ 없으ë©� ë‚˜ìŠ¤ë‹¥ì´ ìƒìž¥ íì§€ë¥� ì‹ ì²­í•� 것으ë¡� 예ìƒí•˜ê³  있으ë©�, ê·� ì´í›„ 주ì‹ì€ OTC í•‘í¬ ì‹œìž¥ì—서 호가ë� ìˆ� 있으ë‚� 확실하지 않습니다.

ModivCare Inc. a déclaré avoir engagé volontairement une procédure de faillite au titre du chapitre 11 le 20 août 2025 et avoir reçu des avis de Nasdaq indiquant qu'elle n'est plus apte à être cotée et qu'elle est en retard dans ses dépôts réglementaires. Nasdaq a décidé d'engager une procédure de radiation et a informé la société que les actions ordinaires seraient suspendues à l'ouverture des transactions le 28 août 2025. La société n'a pas l'intention de faire appel et s'attend à ce que Nasdaq demande la suppression de la cotation; ensuite les actions pourraient être cotées sur le marché OTC Pink, bien que cela ne soit pas assuré.

ModivCare Inc. gab bekannt, dass es am 20. August 2025 freiwillig ein Chapter�11‑Insolvenzverfahren eingeleitet hat und Benachrichtigungen von der Nasdaq erhalten hat, wonach es nicht mehr börsenfähig sei und mit regulatorischen Einreichungen im Rückstand liege. Die Nasdaq hat beschlossen, ein Delisting‑Verfahren einzuleiten, und teilte dem Unternehmen mit, dass die Stammaktien bei Handelsbeginn am 28. August 2025 ausgesetzt werden. Das Unternehmen beabsichtigt nicht, Berufung einzulegen, und erwartet, dass die Nasdaq die Streichung von der Liste beantragen wird; anschließend könnten die Aktien im OTC‑Pink‑Markt gehandelt werden, was jedoch nicht sicher ist.

Positive
  • None.
Negative
  • Voluntary Chapter 11 bankruptcy filing on August 20, 2025 triggering material restructuring
  • Nasdaq determined to commence delisting proceedings due to suitability concerns following the Chapter 11 filing
  • Company is delinquent in filing the Quarterly Report for period ended June 30, 2025, violating Nasdaq Listing Rule 5250(c)(1)
  • Nasdaq scheduled suspension of trading at the opening of business on August 28, 2025
  • Company does not intend to appeal the delisting decision, increasing likelihood of removal from Nasdaq and move to OTC Pink, which is uncertain

Insights

TL;DR: Chapter 11 filing plus Nasdaq delisting and suspension signal severe equity dilution and trading liquidity loss for shareholders.

The Chapter 11 filing on August 20, 2025 triggered Nasdaq delisting proceedings under listing rules related to suitability and led to a delinquency notice for missing a quarterly filing for period ended June 30, 2025. Nasdaq scheduled suspension at market open August 28, 2025 and the company does not intend to appeal, increasing the likelihood of removal from Nasdaq and quotation on OTC Pink. For investors this implies materially reduced liquidity, elevated trading volatility, and high uncertainty about recovery value for equity holders pending the restructuring outcome.

TL;DR: Management disclosed material corporate events transparently but the decision not to appeal delisting removes a regulatory safeguard for shareholders.

The company provided required disclosures and a cautionary note about speculative trading, and directed stakeholders to a court-administered information site. However, electing not to appeal Nasdaq's delisting decision eliminates a potential procedural recourse and signals management acceptance of significant corporate restructuring. This reduces oversight associated with exchange listing standards and shifts stakeholder communications largely to bankruptcy court processes.

ModivCare Inc. ha comunicato di aver avviato volontariamente il procedimento di fallimento ai sensi del Capitolo 11 il 20 agosto 2025 e di aver ricevuto avvisi dalla Nasdaq che non è più idonea alla quotazione e che è in ritardo nelle comunicazioni regolamentari. Nasdaq ha deciso di avviare la procedura di esclusione dalla quotazione e ha informato la società che le azioni ordinarie saranno sospese all'apertura delle contrattazioni il 28 agosto 2025. La società non intende presentare ricorso e prevede che Nasdaq chiederà la rimozione dalla quotazione; successivamente le azioni potrebbero essere negoziate sul mercato OTC Pink, sebbene ciò non sia garantito.

ModivCare Inc. informó que inició voluntariamente procedimientos de bancarrota bajo el Capítulo 11 el 20 de agosto de 2025 y recibió avisos de Nasdaq de que ya no es apta para cotizar y que tiene retrasos en las presentaciones regulatorias. Nasdaq decidió iniciar el proceso de exclusión y notificó a la compañía que las acciones ordinarias se suspenderán a la apertura del mercado el 28 de agosto de 2025. La compañía no piensa apelar y espera que Nasdaq solicite la remoción de la cotización; tras ello las acciones podrían cotizar en el mercado OTC Pink, aunque no es seguro.

ModivCare Inc.ëŠ� 2025ë…� 8ì›� 20ì� ìžë°œì ìœ¼ë¡� 챕터 11 파산 절차ë¥� 개시했으ë©�, 나스닥으로부í„� ë� ì´ìƒ ìƒìž¥ ì ê²©ì„±ì´ 없고 규제 서류 제출ì� ì—°ì²´ë˜ì—ˆë‹¤ëŠ” 통지ë¥� 받았다고 공개했습니다. ë‚˜ìŠ¤ë‹¥ì€ ìƒìž¥íì§€ 절차ë¥� 개시하기ë¡� 결정하고 2025ë…� 8ì›� 28ì� 개장 ì‹� 보통주가 거래정지ë� 것ì´ë¼ê³  회사ì—� 통보했습니다. 회사ëŠ� 항소í•� ì˜ì‚¬ê°€ 없으ë©� ë‚˜ìŠ¤ë‹¥ì´ ìƒìž¥ íì§€ë¥� ì‹ ì²­í•� 것으ë¡� 예ìƒí•˜ê³  있으ë©�, ê·� ì´í›„ 주ì‹ì€ OTC í•‘í¬ ì‹œìž¥ì—서 호가ë� ìˆ� 있으ë‚� 확실하지 않습니다.

ModivCare Inc. a déclaré avoir engagé volontairement une procédure de faillite au titre du chapitre 11 le 20 août 2025 et avoir reçu des avis de Nasdaq indiquant qu'elle n'est plus apte à être cotée et qu'elle est en retard dans ses dépôts réglementaires. Nasdaq a décidé d'engager une procédure de radiation et a informé la société que les actions ordinaires seraient suspendues à l'ouverture des transactions le 28 août 2025. La société n'a pas l'intention de faire appel et s'attend à ce que Nasdaq demande la suppression de la cotation; ensuite les actions pourraient être cotées sur le marché OTC Pink, bien que cela ne soit pas assuré.

ModivCare Inc. gab bekannt, dass es am 20. August 2025 freiwillig ein Chapter�11‑Insolvenzverfahren eingeleitet hat und Benachrichtigungen von der Nasdaq erhalten hat, wonach es nicht mehr börsenfähig sei und mit regulatorischen Einreichungen im Rückstand liege. Die Nasdaq hat beschlossen, ein Delisting‑Verfahren einzuleiten, und teilte dem Unternehmen mit, dass die Stammaktien bei Handelsbeginn am 28. August 2025 ausgesetzt werden. Das Unternehmen beabsichtigt nicht, Berufung einzulegen, und erwartet, dass die Nasdaq die Streichung von der Liste beantragen wird; anschließend könnten die Aktien im OTC‑Pink‑Markt gehandelt werden, was jedoch nicht sicher ist.

false 0001220754 0001220754 2025-08-20 2025-08-20
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): August 20, 2025
 
ModivCare Inc.
(Exact name of registrant as specified in its charter)
 
 
Delaware
001-34221
86-0845127
(State or other jurisdiction of
incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
 
6900 E. Layton Avenue, 12th Floor
Denver, Colorado
 
80237
(Address of principal executive offices)
 
(Zip Code)
 
(720) 258-2130
Registrant’s telephone number, including area code:
 
N/A
Former name or former address, if changed since last report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock, $0.001 par value per share
MODV
The NASDAQ Global Select Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 
 

 
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
 
On August 21, 2025, ModivCare Inc. (the “Company”) received a notification letter (the “Delisting Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq had determined to commence proceedings to delist the Company’s common stock, $0.001 par value per share (the “Common Stock”), from Nasdaq. Nasdaq reached its decision that the Company is no longer suitable for listing pursuant to Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of voluntary proceedings under Chapter 11 of the United States Bankruptcy Code on August 20, 2025.
 
In addition, on August 20, 2025, the Company received a notification letter (the “Delinquency Notice”) from Nasdaq notifying the Company that, because the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2025, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).
 
Nasdaq informed the Company that the Common Stock would be suspended at the opening of business on August 28, 2025. The Company does not intend to appeal Nasdaq’s decision to delist their Common Stock and it is expected that Nasdaq will file a Form 25-NSE with the SEC, which would remove the Company’s common stock from listing and registration on Nasdaq. The Company anticipates that, upon the delisting from Nasdaq, the Common Stock will be quoted on the OTC Pink Market. The Company, however, can provide no assurance that the Common Stock will commence or continue to trade on this market.
 
Item 7.01 Regulation FD Disclosure.
 
On August 22, 2025, the Company issued a press release announcing the information described in Item 3.01 of this Current Report on Form 8-K (this “Current Report”). A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.
 
The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.
 
Additional Information on the Chapter 11 Cases
 
Additional information about the Chapter 11 Cases, including access to Bankruptcy Court documents, is available online at https://www.veritaglobal.net/ModivCare, a website administered by Kurtzman Carson Consultants, LLC d/b/a Verita Global, a third-party bankruptcy claims and noticing agent. The information on this website is not incorporated by reference into, and does not constitute part of, this Current Report.
 
Cautionary Note Regarding the Companys Securities
 
The Company cautions that trading in the Company’s securities during the pendency of the Chapter 11 Cases is highly speculative and poses substantial risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by holders of the Company’s securities in the Chapter 11 Cases.
 
 

 
Cautionary Note Regarding Forward-Looking Statements
 
Certain statements contained in this Current Report on Form 8-K (the “Report”) constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are identified generally by the use of the terms “intended”, “expected”, “will”, and “anticipates”, and similar words or expressions indicating possible future expectations, events or actions. Forward-looking statements are based on current expectations, assumptions, estimates and projections about the Company’s business and its industry, and are not guarantees of future performance. All statements in this Report that are not historical are forward-looking statements, including statements regarding the delisting and deregistration of the Company’s Common Stock from Nasdaq and the timing thereof, and the commencement of trading on the OTC markets.
 
These statements are subject to a number of known and unknown risks, uncertainties and other factors, many of which are beyond the Company’s ability to control or predict, which may cause actual events to be materially different from those expressed or implied herein, including risks and uncertainties relating to the Chapter 11 Cases, including but not limited to, the Company’s ability to obtain Court approval with respect to motions in the Chapter 11 Cases, the effects of the Chapter 11 Cases on the Company and on the interests of various constituents, Court rulings in the Chapter 11 Cases and the outcome of the Chapter 11 Cases in general. The Company has provided additional information about the risks facing its business and the Company in its most recent annual report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 6, 2025, and in its subsequent periodic and current reports on Forms 10-Q and 8-K filed with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statements were made and are expressly qualified in their entirety by the cautionary statements set forth herein and in the periodic and current reports filed with the SEC identified above, which you should read in their entirety before making an investment decision with respect to the Company’s securities. The Company undertakes no obligation to update or revise any forward-looking statements contained in this Report, whether as a result of new information, future events or otherwise, except as required by applicable law.
 
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
Description
99.1
Press Release
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
       
ModivCare Inc.
             
Date: August 22, 2025
     
By:
 
/s/ Faisal Khan
       
Name:
 
Faisal Khan
       
Title:
 
Senior Vice President, General Counsel and Secretary
 
 

FAQ

Why did ModivCare (MODV) receive a Nasdaq delisting notice?

Nasdaq notified ModivCare it will commence delisting proceedings because the company filed for Chapter 11 on August 20, 2025, making it no longer suitable for listing.

Will ModivCare's (MODV) shares be suspended and when?

Nasdaq informed the company the common stock would be suspended at the opening of business on August 28, 2025.

Is ModivCare delinquent on SEC filings?

Yes. Nasdaq issued a delinquency notice because ModivCare is delinquent in filing its Quarterly Report for the period ended June 30, 2025.

Will ModivCare (MODV) remain listed on Nasdaq?

The company does not intend to appeal Nasdaq's decision and expects Nasdaq to file to remove the common stock from Nasdaq listing and registration.

Where might ModivCare's shares trade after Nasdaq delisting?

The company anticipates the common stock may be quoted on the OTC Pink Market, but it cannot assure the stock will commence or continue trading there.

Where can stakeholders find more information about ModivCare's Chapter 11 cases?

Additional information and Bankruptcy Court documents are available at the claims agent website: https://www.veritaglobal.net/ModivCare.
Modivcare Inc

NASDAQ:MODV

MODV Rankings

MODV Latest News

MODV Latest SEC Filings

MODV Stock Data

26.55M
12.09M
16.38%
68.33%
4.64%
Medical Care Facilities
Transportation Services
United States
DENVER